Literature DB >> 11741648

Industry-sponsored clinical research: a double-edged sword.

J S Montaner1, M V O'Shaughnessy, M T Schechter.   

Abstract

Drug development has accelerated exponentially since the 1950s. It is difficult to estimate the relative contributions or rates of success of industry sponsored as opposed to government supported research in any field. However, it is clear that much of the therapeutic innovation of recent decades has emerged from biotechnology and pharmaceutical industry sponsored efforts. This sponsorship is leading to new stresses in the relationship between academic institutions and industry.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2001        PMID: 11741648     DOI: 10.1016/S0140-6736(01)06891-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Early Toronto experience with new standards for industry-sponsored clinical research: a progress report.

Authors:  C David Naylor
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

Review 2.  Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2002-03-23

3.  Getting it right: industry sponsorship and medical research.

Authors:  Patricia Baird
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

4.  Conflicts of interest in science and medicine: the physician's perspective.

Authors:  Delon Human
Journal:  Sci Eng Ethics       Date:  2002-07       Impact factor: 3.525

5.  Conflict of interest and medical publication.

Authors:  Marcus M Reidenberg
Journal:  Sci Eng Ethics       Date:  2002-07       Impact factor: 3.525

Review 6.  Conflict of interest as seen from a researcher's perspective.

Authors:  Arrigo Schieppati; Norberto Perico; Giuseppe Remuzzi
Journal:  Sci Eng Ethics       Date:  2002-07       Impact factor: 3.525

7.  Conflict of interest: it is ethical for an investigator to also be the primary care-giver in a clinical trial.

Authors:  Mark Bernstein
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

8.  Selective serotonin reuptake inhibitors.

Authors:  John R Geddes; Andrea Cipriani
Journal:  BMJ       Date:  2004-10-09

9.  Scientific publications in urology and nephrology journals from China: A 10-year analysis.

Authors:  Xiaomei Zhou; Changyong Xing; Lei Xin; Hongzhen Hu; Liping Li; Jingchuan Fang; Zhiyong Liu
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

10.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.